Detalles de la búsqueda
1.
CSF cutoffs for MCI due to AD depend on APOEε4 carrier status.
Neurobiol Aging
; 89: 55-62, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32029236
2.
Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers.
J Alzheimers Dis
; 69(1): 3-14, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-29914031
3.
Plasma Aß42 as a Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study.
J Alzheimers Dis
; 69(1): 37-48, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30149449
4.
Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease.
J Alzheimers Dis
; 69(1): 49-58, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30958351
5.
Two-Year Longitudinal Monitoring of Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease Using Topographical Biomarkers Derived from Functional Magnetic Resonance Imaging and Electroencephalographic Activity.
J Alzheimers Dis
; 69(1): 15-35, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30400088
Resultados
1 -
5
de 5
1
Próxima >
>>